Nonprofit Chronicles

Journalism about foundations, nonprofits and their impact

Civil rights. Feminism. Gay rights. Environmentalism. Meditation. Yoga. Natural childbirth. Much of the politics and culture of the 1960s has been absorbed into mainstream America. Not psychedelic drugs — not yet, anyway. That will soon change if David Bronner, the CEO of family-owned soap-maker Dr. Bronner’s, has his way. “Psychedelic medicine is the last and arguably the …

Continue reading

MDMA, the man-made drug often called ecstasy or molly, has a colorful history. It was patented in 1914 by the German drug company Merck, and set aside for decades. The US Army studied it during the Cold War, perhaps seeking a chemical weapon or interrogation tool. Alexander “Sasha” Shulgin, an iconoclastic chemist, rediscovered MDMA during …

Continue reading

This is a strange and deeply disturbing time. I’d like to be writing more about racial justice and Covid-19 and, in an indirect way, I did just this morning, at Medium. My story looks at two progressive, criminal-justice ballot initiatives that are all but certain to be on the November ballot in the state of …

Continue reading

Philanthropic dollars helped to create today’s psychedelic renaissance by funding medical research into the therapeutic benefits of psilocybin and LSD. The research has generated a great deal of excitement, as I reported last year in the Chronicle of Philanthropy and in Medium. Now, startup companies want to bring psychedelic medicines to market. That’s the topic …

Continue reading

This is a remarkable moment for psychedelics. Elite universities, including Johns Hopkins and Imperial College in London, have opened centers to research the medical benefits of such drugs as psilocybin, a hallucinogen found in certain mushrooms. The nonprofit Multidisciplinary Association for Psychedelic Research (MAPS) is recruiting people suffering from PTSD to participate in FDA-approved clinical trials using MDMA, better known as …

Continue reading